Kwashiorkor
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
19
|
9
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Dent's disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
23
|
12
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Epithelioid mesothelioma, malignant
|
disease |
Neoplasms
|
Neoplastic Process
|
32
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Morphologically altered structure
|
disease |
|
Anatomical Abnormality
|
46
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Malignant Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
49
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Aspartate aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
57
|
76
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Complete hydatidiform mole
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
61
|
3
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Gestational trophoblastic disease
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
75
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Metabolic acidosis
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
85
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Experimental Autoimmune Encephalomyelitis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Experimental Model of Disease
|
97
|
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Gestational Trophoblastic Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
98
|
7
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Uveomeningoencephalitic Syndrome
|
disease |
Eye Diseases; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
102
|
27
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Conn Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
107
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cystadenocarcinoma, Serous
|
disease |
Neoplasms
|
Neoplastic Process
|
110
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
invasive cancer
|
phenotype |
Neoplasms
|
Neoplastic Process
|
146
|
15
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Oropharyngeal disorders
|
group |
Digestive System Diseases; Respiratory Tract Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
163
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Central Serous Chorioretinopathy
|
disease |
Eye Diseases
|
Disease or Syndrome
|
211
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Atherosclerotic lesion
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
253
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
TARSAL-CARPAL COALITION SYNDROME
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
261
|
13
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Childhood Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
335
|
20
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |